Stoke TherapeuticsNASDAQ: STOK: Develops RNA-based therapies for severe genetic disorders.
10+ YOE5+ Mgmt10+ years CMC experience with drug-device combination products, 5+ years CMC leadership, bachelor's required (advanced degree preferred), deep CMC/regulatory knowledge, strong communication and cross-functional leadership.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
10+ YOEBS in life sciences, 10+ years regulatory CMC or related pharma experience, experience with peptides and injectable dosage forms, ability to author CMC submissions and coordinate cross-functional inputs.
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
10+ YOE10+ years biopharma CMC regulatory experience for biologics/gene therapies; bachelor’s or master’s in life sciences; experience with post-approval CMC submissions, GMP and global regulatory frameworks; strong communication and cross-functional skills.
CSLASX: CSL: Develops and manufactures biopharmaceutical products and vaccines.
5+ YOERegulatory CMC leadership role requiring 5+ years in regulatory affairs for biologics/plasma, with cross-functional collaboration and international submissions.
Regulatory submissions, Regulatory intelligence, Change control, Due diligence, SOPs
Korsana BiosciencesNASDAQ: CYCN: Develops novel therapies to treat neurodegenerative diseases.
15+ YOE5+ MgmtPh.D. in relevant sciences or equivalent MS/BS experience; 15+ years in biologics development and manufacturing, including 5+ years as a CMC head; successful IND, IMPD, BLA, or MAA submissions and approvals.
AstraZenecaLondon Stock Exchange: AZN: Researches, develops, and manufactures prescription medicines for major diseases.
7+ YOE7+ years pharmaceutical/biopharma CMC experience, bachelor\u0002s required (advanced degree preferred), IND/IMPD and IND-enabling experience, process and analytical development, cross-functional leadership and regulatory authorship experience.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
7+ YOE7+ years pharmaceutical/biopharma CMC development and manufacturing experience; Bachelor\u0002s required (advanced degree preferred); IND-enabling and process/analytical development experience; cross-functional leadership and strategic decision-making.
Vor BioNASDAQ: VOR: Developing targeted therapies for chronic autoimmune diseases.
8+ YOEDoctorate preferred; ≥8 years Regulatory CMC biologics experience with FDA sCDER interactions, global submissions, lifecycle management, and biologics/combination product development.
ModernaNasdaq: MRNA: Develops and manufactures messenger RNA medicines and vaccines.
15+ YOEDegree in life sciences or related field, 15 years relevant experience (or 10 years with PhD), deep stability science and CMC judgment, experience with stability strategy, regulatory submissions, leadership and cross-functional collaboration.
Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
12+ YOEBachelor's in relevant science required; 12+ years regulatory CMC experience (10+ with advanced degree); direct CMC experience for biologics/cell & gene therapies; knowledge of FDA/EMA/ICH and eCTD submissions.
Oruka TherapeuticsNASDAQ: ORKA: Develops long-acting biologics for chronic skin and inflammatory diseases.
6+ YOEMaster's or PhD in life sciences, 6+ years CMC experience with minimum 3+ years regulatory CMC in biologics, cGMP and global regulatory submission expertise (FDA/EMA/ICH), experience authoring Module 3 and combination product submissions.
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
12+ YOEBachelor’s degree in a scientific discipline and 12+ years of Regulatory CMC experience in biotech or pharma, including global registration, submissions, health authority interactions, and cross-functional leadership.
FDA, EMA, ICH, INDs, IMPDs, NDA, MAA, CTD Module 3
Madrigal PharmaceuticalsNASDAQ: MDGL: Develops and commercializes therapeutics for metabolic dysfunction-associated steatohepatitis.
12+ YOEBS in life sciences or equivalent experience (advanced degree preferred); minimum 12 years relevant experience with 8-10 years regulatory CMC experience; strategic CMC regulatory expertise; experience with global health authorities; strong communication and negotiation skills.
Broadmeadows or King of Prussia or Melbourne or Waltham
OnsiteFull Time
CSLASX: CSL: Global biotechnology producing plasma-derived and recombinant therapies.
5+ YOEBachelor's degree in biological or chemical sciences or related field; 5+ years of progressive regulatory experience in biologics or plasma; expertise in global regulations, CMC submissions, compliance, and cross-functional leadership.
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
7+ YOE7+ years pharmaceutical product development and manufacturing experience; Bachelor's degree required (advanced degree preferred); IND-enabling CMC, process and analytical development, project leadership, cross-functional collaboration.
Cambridge or Research Triangle Park or San Francisco
$204k-$281k/yrHybridFull Time
BiogenNASDAQ: BIIB: Develops therapies for neurological and neurodegenerative diseases.
12+ YOE12+ years' experience in matrix leadership with CMC/supply chain or life cycle management; BS required, advanced degree preferred; alliance and financial management experience; strong strategic, communication and risk-management skills.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
12+ YOEExtensive CMC leadership for small molecule development through IND/NDA/MAA; technical, regulatory and project leadership with strong communication and strategic skills.
Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
12+ YOE12+ years regulatory affairs CMC experience in pharma/biotech, advanced scientific degree required, strong regulatory negotiation and submission experience (INDs/BLAs/MAAs), leadership and communication skills.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
10+ YOEAdvanced degree in life sciences or engineering,10+ years CMC development experience with leadership, expertise in nucleic acid/LNP manufacturing and analytics, regulatory submission experience, strong risk management and communication skills.